B&G Foods vs Cal-Maine Foods
BGS and CALM side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BGS and CALM compare
Cal-Maine Foods is the larger company, worth 11 times as much as B&G Foods ($3.1B against $284M).
B&G Foods grew revenue faster over the last twelve months (−2.7% versus −42.5% for Cal-Maine Foods).
Cal-Maine Foods keeps more of each dollar of sales as profit, with a net margin of 2.3% compared with −4.7% at B&G Foods.
Both pay dividends: B&G Foods yields 16.3% and Cal-Maine Foods 1.6%.
Cal-Maine Foods scores higher on the StockData Score (12 against 10 for B&G Foods), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BGS | CALM |
|---|---|---|
| Size and price | ||
| Market cap | $284M | $3.1B |
| Share price | $3.50 | $66.45 |
| Change, 1 year | −25.1% | −26.9% |
| Change, 5 years | −88.6% | 80.6% |
| Beta (5Y) | 0.49 | 0.37 |
| Employees | 2,497 | 4,909 |
| StockData Score | ||
| Total score | 10 | 12 (better) |
| Valuation score | 3 | 3 |
| Growth score | 2 (better) | 0 |
| Performance score | 0 | 2 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 4 (better) | 1 |
| Valuation | ||
| P/E | – | 56.8× |
| P/S | 0.2× (better) | 1.2× |
| P/B | 0.8× (better) | 1.2× |
| EV/EBITDA | 17.9× | 16.0× (better) |
| P/FCF | 2.9× | – |
| FCF yield | 35.0% (better) | −1.1% |
| Fair value | $13.74 | $88.06 |
| Margin of safety | 74.5% (better) | 24.5% |
| Growth | ||
| Revenue growth (TTM) | −2.7% (better) | −42.5% |
| Revenue growth, 5Y average | −1.5% | 16.6% (better) |
| Net income growth (TTM) | – | −95.4% |
| EPS growth (TTM) | – | −95.5% |
| EPS growth, 5Y average | – | 178% |
| Profitability | ||
| Gross margin | 21.8% (better) | 14.3% |
| Operating margin | 3.7% (better) | 0.74% |
| Net margin | −4.7% | 2.3% (better) |
| FCF margin | 5.6% (better) | −1.3% |
| Return on equity | −20.4% | 2.2% (better) |
| Return on invested capital | 2.2% (better) | 0.99% |
| Financial health | ||
| Debt / equity | 5.75 (better) | 0.00 |
| Net debt / EBITDA | 15.68 | – |
| Current ratio | 2.84 | 7.70 (better) |
| Altman Z-score | 1.14 | 6.92 (better) |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 16.3% (better) | 1.6% |
| Payout ratio | – | 200% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −16.7% | 135% (better) |
| Shareholder yield | 16.3% (better) | 1.6% |
| Ownership | ||
| Held by institutions | 57.3% | 95.7% |
| Held by insiders | 5.3% | 36.4% |
| Insider net buying, 12 months | −$248K | – |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 18.4% | 21.8% |
Go deeper
- BGS stock overview
- BGS income statement
- BGS valuation and score
- CALM stock overview
- CALM income statement
- CALM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.